5.19
Oncology Institute Inc Aktie (TOI) Neueste Nachrichten
The Oncology Institute Announces Second Quarter 2026 Financial Results Conference Call - Quiver Quantitative
The Oncology Institute's Q2 results call will stream online Aug. 6 - Stock Titan
Oncology Institute Inc (TOI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oncology Institute Inc (TOI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncology Institute Inc (TOI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oncology Institute Inc (TOI) Income Statement - TradingKey
Oncology Institute Inc (TOI) Cash Flow - TradingKey
Oncology Institute Inc (TOI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oncology Institute Inc (TOI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
The Oncology Institute Inc. (TOI) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline, Revenue Uncertainty Caps StockCFO Commentary Report - dars.gov.et
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
The Oncology Institute (TOI) Sheds Nearly 2% Amidst Sector Headwinds, Support TestedLeading Diagonal - dars.gov.et
Oncology Institute, Inc. (TOI) 10% owner adds 18,000 shares in open-market buy - Stock Titan
Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95 - Bitget
Oncology institute CMO Yale Podnos sells $150k in shares By Investing.com - Investing.com South Africa
Form 4 Oncology Institute Inc For: 16 July By Investing.com - Investing.com Nigeria
Oncology Institute, Inc. (TOI) CMO sells 23,452 shares after option exercises - Stock Titan
Oncology institute CMO Yale Podnos sells $150k in shares - Investing.com
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10? - Yahoo Finance
The Oncology Institute Inc. (TOI) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost ControlsUpward Estimate Revision - dars.gov.et
The Oncology Institute Warrant (TOIIW) Stalls at $0.07 as Trading Remains FlatETF Creation Redemption - dars.gov.et
Form 144 The Oncology Institute For: 14 July By Investing.com - Investing.com Nigeria
TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00 - Stock Titan
Form 4 Oncology Institute Inc For: 13 July By Investing.com - Investing.com Australia
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock - Investing.com UK
Oncology institute: 10% owner Jorey Chernett buys $87,750 stock By Investing.com - Investing.com Nigeria
Oncology Institute (TOI) major holder buys 15,000 shares in open market - Stock Titan
DFPH SEC FilingsOncology Institute, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
The Oncology Institute (TOI) Proxy filing Summary - Quartr
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Oncology Institute (TOI) Short Interest & Short Float | Updated Jul 2026 $TOI - MarketBeat
Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG - Moomoo
Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant - Stock Titan
Oncology Institute (TOI) director receives 25,833 fully vested RSU shares - Stock Titan
TOI Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG raises Oncology Institute stock price target to $9 on debt refinancing By Investing.com - Investing.com South Africa
BTIG raises Oncology Institute stock price target to $9 on debt refinancing - Investing.com Nigeria
BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Oncology Institute Refinances Debt with New Term Loan - TipRanks
Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi - Stock Titan
Needham Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Oncology Institute refinances $86m debt with OrbiMed By Investing.com - Investing.com Nigeria
Enterprise value to revenue forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Oncology Institute refinances $86m debt with OrbiMed - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):